In Thursday’s Wall Street session, Genius Sports Limited (NYSE:GENI) shares traded at $9.88, up 0.30% from the previous session.
GENI stock price is now -2.26% away from the 50-day moving average and 12.38% away from the 200-day moving average. The market capitalization of the company currently stands at $2.51B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $11 to $12, BTIG Research maintained Buy rating for Genius Sports Limited (NYSE: GENI). On April 21, 2025, Deutsche Bank recently initiated its ‘Buy’ rating on the stock quoting a target price of $12, while ‘B. Riley Securities’ rates the stock as ‘Buy’
In other news, Burns Daniel Paul, Director bought 8,157 shares of the company’s stock on May 13 ’25. The stock was bought for $85,222 at an average price of $10.45. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 06 ’25, Officer Stevens Eric bought 79,373 shares of the business’s stock. A total of $744,519 was incurred on buying the stock at an average price of $9.38. A total of 9.90% of the company’s stock is owned by insiders.
During the past 12 months, Genius Sports Limited has had a low of $5.03 and a high of $11.40. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 2.32, and a quick ratio of 1.42. The fifty day moving average price for GENI is $10.1084 and a two-hundred day moving average price translates $8.79125 for the stock.
The latest earnings results from Genius Sports Limited (NYSE: GENI) was released for 2025-03-31. The net profit margin was -8.54% and return on equity was -7.25% for GENI. The company reported revenue of $143.99 million for the quarter, compared to $119.72 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 20.28 percent.
